Vol 7, Supplement 4 (September 2018): Translational Andrology and Urology (Personalized Prostate Cancer Care)

Preface

Personalized prostate cancer care
Soroush Rais-Bahrami, Jennifer B. Gordetsky

Review Article

Rethinking active surveillance for prostate cancer in African American men
Gabriel Z. Leinwand, Andrew T. Gabrielson, Louis S. Krane, Jonathan L. Silberstein
MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
Zachary A. Glaser, Kristin K. Porter, John V. Thomas, Jennifer B. Gordetsky, Soroush Rais-Bahrami
Prostate imaging features that indicate benign or malignant pathology on biopsy
Catherine Elizabeth Lovegrove, Mudit Matanhelia, Jagpal Randeva, David Eldred-Evans, Henry Tam, Saiful Miah, Mathias Winkler, Hashim U. Ahmed, Taimur T. Shah
Urinary markers aiding in the detection and risk stratification of prostate cancer
Nicholas Raja, Christopher M. Russell, Arvin K. George
Entering an era of radiogenomics in prostate cancer risk stratification
Nachiketh Soodana-Prakash, Radka Stoyanova, Abhishek Bhat, Maria C. Velasquez, Omer E. Kineish, Alan Pollack, Dipen J. Parekh, Sanoj Punnen
Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer
Marcin Czarniecki, Filippo Pesapane, Bradford J. Wood, Peter L. Choyke, Baris Turkbey
Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer
Samuel J. Galgano, Roberto Valentin, Jonathan McConathy
Clinical significance of subtypes of Gleason pattern 4 prostate cancer
Oudai Hassan, Andres Matoso
Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer
Meenal Sharma, Hiroshi Miyamoto
Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways
Eric Eidelman, Hemantkumar Tripathi, De-Xue Fu, M. Minhaj Siddiqui
Developing a personalized template for lymph node dissection during radical prostatectomy
Ram A. Pathak, Ashok K. Hemal
Emerging role of cytoreductive prostatectomy in patients with metastatic disease
Yasmeen Jaber, Chad A. Reichard, Brian F. Chapin